We found that anti-CD20 alone could mediate ADCC with increasing concentrations of antibody using Raji (AUC 50,712), SU-DHL-4 (11,125), NU-DUL-1 (AUC 6,535), and SU-DHL-8 (AUC 22,929) lymphoma targets (Figure 4B). The gene discussed is MS4A1; the disease is lymphoma.